Cureatr

Cureatr

Cureatr launched in 2012 as a secure, HIPAA-compliant texting app for clinicians, co-founded by Alex Khomenko and Joseph Mayer. The company initially competed with TigerText and Voalte in the clinical-communications market before pivoting to medication management around 2017. That shift moved the firm from a horizontal communication layer to a vertical workflow tool embedded in electronic health record systems. The platform focused on medication reconciliation — the process of creating an accurate list of all medications a patient is taking as they move between hospitals, nursing facilities, and home. Cureatr's software ingested data from pharmacies, pharmacy benefit managers, and EHRs to flag discrepancies and alert care teams. Customers included health systems like Mount Sinai Health System and Northwell Health. The company raised venture funding from Deerfield Management, Cerner, and Cardinal Health, reflecting its hybrid position between health IT and health services. The firm operated from New York with remote teams. Its last publicly announced funding round was a $13 million Series B extension in 2018 led by Deerfield Management, bringing total disclosed funding to roughly $44 million. Headcount and deployment figures were not publicly disclosed. In March 2024, Altera Digital Health, a portfolio company of N. Harris Computer Corporation, acquired Cureatr to integrate its medication reconciliation capabilities into the Paragon EHR platform. Cureatr's structural edge was its focus on a narrow, measurable clinical problem — medication reconciliation — at a time when most health IT startups pursued broad telehealth or AI platforms. The acquisition by Altera validates the thesis that point solutions addressing a specific, well-documented source of medical error can become bolt-on acquisitions for larger EHR vendors seeking to differentiate their suites.